Användning av cookies

Lunds universitet använder cookies för att se till att webbplatsen fungerar korrekt och för att förbättra din upplevelse.

Läs mer i vår cookiepolicy

Sökresultat

Filtrera

Nollställ filter

Filtyp

Din sökning på "*" gav 125731 sökträffar

Molecular Virology

Human papillomavirus (HPV) infections cause 500.000 cases of cervical cancer each year in the world (400 cases in Sweden), and 250.000 deaths (120 cases in Sweden). HPV16 is the most common cancer-associated HPV type. The majority of all HPV16 infections is cleared by the host but a fraction persists that may cause cancer. The full life cycle of HPV16 requires cell proliferation at the early stage

https://www.virology.lu.se/molecular-virology - 2026-04-23

Joakim Esbjörnsson, Ph.D.

Principal Investigator, Associate Professor in Virology “What would be easy turned out to be difficult. That is one way of summarising over 30 years of efforts to find a vaccine or a cure for HIV, the virus that causes the disease AIDS. It is this scientific challenge that triggers the researcher Joakim Esbjörnsson.” From “Forskarnas Nyheter”(2017) Joakim Esbjörnsson is an Associate senior lecture

https://www.virology.lu.se/systems-virology/joakim-esbjornsson-phd - 2026-04-23

Pandemics and alertness

The Covid-19 pandemic has clearly demonstrated how fast viruses can become a significant threat to global health. Through national and international collaboration, we can improve our readiness for future virus outbreaks.Pandemics and alertness | Lund UniversityLinkedIn_Pandemics_and alertness

https://www.virology.lu.se/pandemics-and-alertness - 2026-04-23

Tumor Virology

The field of tumor virology has provided groundbreaking insights into the causes of human cancer. In my research at Lund University I focus on I) characterization of human papillomavirus (HPV)-associated mechanisms for disease development and II) use of HPV for prevention of disease.Concerning HPV-associated benign tumors as recurrent laryngeal papilloma, we study de-regulated pathways of the loca

https://www.virology.lu.se/tumor-virology - 2026-04-23

Projects

Laryngeal Papilloma Interaction between HPV, respiratory bacteria, and a dysfunctional local immune response may promote laryngeal papilloma.  Although presence of human papillomavirus (HPV)-vaccines, there are new cases of HPV-diseases. Such a disease is laryngeal papilloma (LP) which is a benign tumor that can persist during life and is considered incurable, manifested by obstruction in the resp

https://www.virology.lu.se/tumor-virology/projects - 2026-04-23

Ola Forslund (PI)

Principal Investigator, Associate Professor in VirologyOla Forslund is a Senior Lecturer in Tumor Virology and Associate Professor in Virology at the Department of Translational Medicine, Medical Faculty at Lund University. Ola received his Ph.D in 1997 at Lund University, and performed postdoctoral studies at Umeå University and as a visiting research fellow at IMVS in Adelaide. From 2000 he was

https://www.virology.lu.se/tumor-virology/ola-forslund-pi - 2026-04-23

Contact

Associate Professor Ola Forslund, Ph.D.Department of Translational MedicineLund UniversitySölvegatan 23B221 85 Lund, SwedenPhone +46 46-17 19 08Mobile +46 70 33 26 950E-mail: ola [dot] forslund [at] med [dot] lu [dot] se (Ola[dot]forslund[at]med[dot]lu[dot]se)

https://www.virology.lu.se/tumor-virology/contact - 2026-04-23

Publications

Joakim Esbjörnsson Joakim Esbjörnsson_LUCRISJoakim Esbjörnsson_PubMedReview articles and invited publications in peer-reviewed international journals Esbjörnsson J, Jansson M, Jespersen S, Månsson F, Hønge BL, Lindman J, Medina C, da Silva ZJ, Norrgren H, Medstrand P, Rowland-Jones SL, Wejse C. HIV-2 as a model to identify a functional HIV cure. AIDS Res Ther. 2019 Sep 5;16(1):24. doi: 10.1186/s12

https://www.virology.lu.se/systems-virology/publications - 2026-04-23

HIV Host interactions

There are two types of HIV, HIV-1 and HIV-2, which can lead to AIDS. HIV-1, with global spread, is the more aggressive and infectious virus. The reason for the difference in pathogenesis between HIV-1 and HIV-2 is not yet clear, and neither is the inhibiting effect that HIV-2 has on HIV-1 in dually infected understood. Our research is focused on understanding the interactions between the immune sy

https://www.virology.lu.se/hiv-host-interactions - 2026-04-23

Collaborators

National Cecilia Ahlström-Emanuelsson - Ear, Nose and Throat Diseases, Lund University Jan Albert - Department of Microbiology, Tumor and Cell Biology, Karolinska Institute Anna Karin Pereira Bastos - Ear, Nose and Throat Diseases, Trelleborg Hospital Per Björkman - Clinical infection medicine, Lund University Stefan Freccero - Ear, Nose and Throat Diseases, Trelleborg Hospital Marianne Jansson -

https://www.virology.lu.se/systems-virology/collaborators - 2026-04-23

Contact

Joakim Esbjörnsson, PhDAssociate Professor in VirologySenior Lecturer in Medical MicrobiologyHead of Systems Virology GroupDepartment of Translational MedicineFaculty of MedicineLund UniversityPostal address:Lund UniversityBMC, B13221 84 LundSwedenPhone: +46 46 22 20119, Officeemail: joakim [dot] esbjornsson [at] med [dot] lu [dot] se   Honorary Visisting Research Fellow Nuffield Department of Med

https://www.virology.lu.se/contact - 2026-04-23

Projects

Acute HIV-1 infectionViral evolution and innate immune responses during acute adult HIV-1 infection and their association with disease pathogenesisIt has been suggested that different virological and immunological events during the very early stages of HIV infection may determine the rate of the future disease course of the individual patient. Previous studies by us and others have suggested that

https://www.virology.lu.se/virology.lu.se/systems-virology - 2026-04-23